8 November 2026RSS feed
PR●Press Release IndiaTHE BUSINESS ANNOUNCEMENT WIRE
Business announcements.
Direct from the source.
NEWSROOM / INDIA

Releases by dssenthil

Browse announcements from the Press Release India archive.

UPDATED THROUGHOUT THE DAY
Business wire8896

WNS Launches New Delivery Center in Hyderabad

WNS (Holdings) Limited (NYSE: WNS), a leading provider of global Business Process Management (BPM) solutions, today announced the launch of a new delivery center in Hyderabad, Telangana, India. As a part of WNS’ global delivery network, this facility will focus

Business wire8897

FPT Expands Global Presence with New Subsidiary in Dalian, China

Global IT company FPT announced the inauguration of its new extension in China, FPT Dalian. Leveraging its highly skilled workforce with diverse language proficiencies, the new subsidiary is poised to enhance support to companies in Japan and China, with a futu

Business wire8902

Ant International Kicks Off Global Campaign for UEFA EURO 2024

Ant International, Official Partner of UEFA Euro 2024, with campaigns by Alipay+, Antom and WorldFirst, the company's flagship digital payment services, seeks to engage fans around the world in the lead up to the event Leading retail stores, airports and F&B o

Business wire8906

First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries Under Collaboration of The Max Foundation, BeiGene, and the BeiGene Foundation

The Max Foundation (Max), a global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and supportive services to patients worldwide, BeiGene, a global oncology company, and the BeiGene Foundation, a nonprofit ch

Business wire8908

Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia

− Pre-Specified Interim Analysis Shows Positive Safety and Efficacy Results; Mezagitamab Safe and Well Tolerated −Takeda Intends to Initiate a Global Phase 3 Trial of Mezagitamab in Patients with Primary Immune Thrombocytopenia in Fiscal Year 2024 − Late-Stage

Business wire8909

PUMA Reduces Greenhouse Gas Emissions by 24% in 2023

Sports company PUMA reduced its greenhouse gas emissions by 24% in 2023 compared to 2022, despite a strong sales growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313721861/en/ Sports company